Molecular Partners Announces Publication in Cancer Immunology Research of Preclinical Data Supporting MP0533's Proposed Mechanism of Action
Preclinical data of tetra-specific T cell engager MP0533 demonstrate preferential T cell mediated killing of AML cells, while sparing healthy cellsResults highlight MP0533-mediated T-cell activation...
United States Seth Lewis Laura Jeanbart University Of Bern Cancer Immunology Research American Association For Cancer Research
Source: marketscreener.com